You need to enable JavaScript to run this app.
FDA updates guidance on reporting manufacturing disruptions for finished products and APIs
Regulatory News
Joanne S. Eglovitch
North America
Pharmaceuticals
Regulatory NewsJoanne S. Eglovitch
North AmericaPharmaceuticalsRegulatory NewsJoanne S. EglovitchNorth AmericaPharmaceuticals